Cannabis Weekly Round-Up: New Merger in the Public Markets
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the past trading week.
Your trusted source for investing success
Your trusted source for investing success
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the past trading week.
HPQ Silicon Resources Inc (TSXV:HPQ) is pleased to inform shareholders that PyroGenesis Canada Inc (“PyroGenesis”) (TSX Venture:PYR) has confirmed that process improvements and design modifications are generating results that exceed expectations at this stage of development.
RedZone Resources Inc. (TSXV:REZ) (“the Company” or “RedZone”) is pleased to announce the appointment of Mr. Jean-Philippe Paiement to the Company’s advisory board. Mr. Paiement currently works for a leading mining focused private equity fund.
Lexaria Bioscience Corp. (CSE:LXX,OTCQB:LXRP) (the “Company” or “Lexaria”), a drug delivery platform innovator, is pleased to announce positive topline results upon completion of its first ingestible nicotine in vivo (animal) absorption study.
ChroMedX Corp. (CSE:CHX) (OTCQB:CHXIF) (FSE:EIY2) (the “Company”), developer of the HemoPalm Handheld Blood Analyzer Platform, is pleased to announce the appointment of Michaela Shaw as Director of Quality Assurance and Regulatory Assurance.
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the past trading week.
Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP), a drug delivery platform innovator, announces it has received another new Notice of Allowance from the United States Patent and Trademark Office (“USPTO”) providing claims that protect processes for making specific compositions of matter for enhanced cannabinoid delivery utilizing its DehydraTECH(TM) technology.
HPQ Silicon Resources Inc. (TSXV:HPQ) is pleased to inform shareholders that its newly created subsidiary, Solar Blockchain Energies Inc. (“SBEI”), has entered into a Memorandum of Understanding (“MOU”) with an Undisclosed Blockchain Company (“UBC”) to advise, develop and implement a new set of blockchain solutions for the monetization of solar
By Amanda Kay
What are the small-cap cannabis stocks on the market? And which could be the next to make gains? Our overview includes details on a variety of companies.
A few months into 2018 soon to finish the first quarter, the INN takes a look at the 5 top pharma stocks on the NASDAQ year-to-date.
By Pia Rivera
Lexaria Bioscience Corp. (OTCQX:LXRP,CSE:LXX) (the “Company” or “Lexaria”) announces warrant transactions.
The Investing News Network rounds some of the biggest news in the cannabis market for the past trading week.
Lexaria Bioscience Corp. (CSE:LXX,OTCQB:LXRP) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces it has received a new Notice of Allowance from the United States Patent and Trademark Office (“USPTO”) providing for “composition of matter” claims that protect the specific combination of substances which enable improved taste and bioabsorption
BioSyent (TSXV:RX) released today a summary of its financial results for the three and twelve months ended December 31, 2017.
As quoted in the press release:
“BioSyent had a strong finish to 2017 with both our Canadian and International Pharmaceutical businesses posting record quarterly sales in Q4,” commented René Goehrum, President and
Vodis Pharmaceuticals Inc. (CSE:VP,FSE:1JV1) (“Vodis” or the “Company”) provides an update on operations in Canada and the United States. Since the fall of 2017, the Company’s Canadian operations have met the challenges of working capital requirements while it navigated the Health Canada licensing approval process.
Lexaria Bioscience Corp. (CSE:LXX,OTCQB:LXRP) (the ”Company” or ”Lexaria”), a drug delivery platform innovator, is pleased to announce it has filed a new patent application with the United States Patent and Trademark Office (”USPTO”) for use of DehydraTECHTM to improve the speed and quantity of absorption of active pharmaceutical ingredients
Through their multiple holdings, ETFs provide immediate diversification to buyers. That’s particularly important in the medical device market.
By Pia Rivera
HPQ Silicon Resources Inc. (TSXV:HPQ, FRANKFURT:UGE, OTC PINK:URAGF) is pleased to inform shareholders that PyroGenesis Canada Inc., (“PYR” or “PyroGenesis) provided a general update on the PUREVAP™ Project.
By Pia Rivera
Lexaria Bioscience Corp. (OTCQX:LXRP, CSE:LXX) is pleased to announce that it has commenced its first nicotine in vivo (animal) absorption and tolerability study.
Chi-Med, a China-based biopharmaceutical company, is making a name for itself within the oncology field at a global scale.
